We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIAF bioAffinity Technologies Inc

0.00 (0.0%)
Pre Market
Last Updated: 07:28:49
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 1.45
Ask Price 1.57
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
bioAffinity Technologies Inc BIAF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.50 07:28:49
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.9548 - 3.99
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 1.50 USD

bioAffinity Technologies Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
14.25M 9.50M - 5k -8.15M -0.86 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

bioAffinity Technologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BIAF Message Board. Create One! See More Posts on BIAF Message Board See More Message Board Posts

Historical BIAF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.501.751.461.6357,3670.000.0%
1 Month1.481.751.351.5820,5460.021.35%
3 Months1.671.75890.95481.4412,311-0.17-10.18%
6 Months1.832.150.95481.6212,765-0.33-18.03%
1 Year2.803.990.95482.72339,329-1.30-46.43%
3 Years8.4015.550.95483.96771,546-6.90-82.14%
5 Years8.4015.550.95483.96771,546-6.90-82.14%

bioAffinity Technologies Description

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |